Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,850 | 7 | 98.1% |
| Travel and Lodging | $189.09 | 6 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals America, Inc. | $10,039 | 13 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $10,039 | 13 | Takeda Pharmaceuticals America, Inc. ($10,039) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/10/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,450.00 | General |
| Category: Gout/Rheumatology | ||||||
| 04/10/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Travel and Lodging | Cash or cash equivalent | $33.17 | General |
| Category: Gout/Rheumatology | ||||||
| 04/03/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Gout/Rheumatology | ||||||
| 04/03/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Travel and Lodging | Cash or cash equivalent | $22.50 | General |
| Category: Gout/Rheumatology | ||||||
| 03/28/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,450.00 | General |
| Category: Gout/Rheumatology | ||||||
| 03/28/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Travel and Lodging | Cash or cash equivalent | $18.40 | General |
| Category: Gout/Rheumatology | ||||||
| 03/10/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Gout/Rheumatology | ||||||
| 02/22/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,450.00 | General |
| Category: Gout/Rheumatology | ||||||
| 02/22/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Travel and Lodging | Cash or cash equivalent | $27.00 | General |
| Category: Gout/Rheumatology | ||||||
| 01/10/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,450.00 | General |
| Category: Gout/Rheumatology | ||||||
| 01/10/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Travel and Lodging | Cash or cash equivalent | $55.62 | General |
| Category: Gout/Rheumatology | ||||||
| 01/03/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,450.00 | General |
| Category: Gout/Rheumatology | ||||||
| 01/03/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Travel and Lodging | Cash or cash equivalent | $32.40 | General |
| Category: Gout/Rheumatology | ||||||
About Dr. Michael Sugarman, M.D
Dr. Michael Sugarman, M.D is a Rheumatology healthcare provider based in Fullerton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922094028.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Sugarman, M.D has received a total of $10,039 in payments from pharmaceutical and medical device companies, with $10,039 received in 2017. These payments were reported across 13 transactions from 1 company. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,850).
Practice Information
- Specialty Rheumatology
- Location Fullerton, CA
- Active Since 09/23/2005
- Last Updated 04/25/2013
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1922094028
Products in Payments
- Uloric (Drug) $10,039
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.